Comparison of [14C]FMAU, [3H]FEAU, [14C]FIAU, and [3H]PCV for monitoring reporter gene expression of wild type,and mutant herpes simplex virus type 1 thymidine kinase in cell culture

被引:37
作者
Kang, KW
Min, JJ
Chen, XY
Gambhir, SS
机构
[1] Stanford Univ, Dept Radiol, Bio X Program, Stanford, CA 94305 USA
[2] Natl Canc Ctr, Dept Nucl Med, Goyang, South Korea
[3] Chonnam Natl Univ, Sch Med, Dept Nucl Med, Kwangju, South Korea
关键词
gene therapy; thymidine kinase; C-14]FMAU; H-3]FEAU; C-14]FIAU; H-3]PCV; HSV1-tk; HSV1-sr39tk; reporter gene;
D O I
10.1007/s11307-005-0010-7
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To assess the optimal reporter probe/reporter gene combination for monitoring herpes simplex virus type 1 thymidine kinase (HSV1-tk) gene expression, we compared the cellular uptake of 1-(2'-fluoro-2'-deoxy-D-arabinofuranosyl)-5-methyluracil (FMAU), 2-fluoro-2-deoxyarabinofuranosyl-5-ethyluracil (FEAU), 2'-fluoro-2-deoxy-beta-D-arabinofuranosyl-5-iodouracil (FIAU) and penciclovir (PCV) in both HSV1-tk and HSV1-sr39tk expressing cells. Procedures: For stably transfected cell studies, C6 rat glioma cells, C6 HSV1-tk transfectant, C6 mutant HSV1-sr39tk transfectant, rat Morris hepatoma cells (MH3924A), and MH3924A HSV1-tk transfectant cells were used. For adenoviral infection studies, C6 rat glioma cells were exposed to serial titers of AdCMV-HSV1-tk AdCMV-HSV1-sr39tk or AdCMV-fluc for 24 hours. These cells were incubated with [C-14]FMAU, [H-3]FEAU, [C-14]FIAU, and [H-3]PCV, and cellular uptake of radioactivity was measured. Results: [3 H]FEAU exhibited the highest or second highest accumulation and the most selectivity regardless of the mode of gene transfer for both HSV1-tk and mutant HSV1-sr39tk reporter genes. Conclusion: This combination of high accumulation and high selectivity for both HSV1-tk and HSV1-sr39tk makes suitably radiolabeled FEAU a promising candidate as a radiotracer for imaging HSV1-tk/HSV1-sr39tk gene expression in living subjects.
引用
收藏
页码:296 / 303
页数:8
相关论文
共 37 条
[1]  
ABBRUZZESE JL, 1989, INVEST NEW DRUG, V7, P195
[2]   Evaluation of 2′-Deoxy-2′-Flouro-5-Methyl-1-β-D-Arabinofuranosyluracil as a Potential Gene Imaging Agent for HSV-tk Expression In Vivo [J].
Alauddin, Mian M. ;
Shahinian, Atranik ;
Gordon, Erlinda M. ;
Conti, Peter S. .
MOLECULAR IMAGING, 2002, 1 (02) :74-81
[3]   Direct Comparison of Radiolabeled Probes FMAU, FHBG, and FHPG as PET Imaging Agents for HSV1-tk Expression in a Human Breast Cancer Model [J].
Alauddin, Mian M. ;
Shahinian, Atranik ;
Gordon, Erlinda M. ;
Conti, Peter S. .
MOLECULAR IMAGING, 2004, 3 (02) :76-84
[4]   Synthesis and preliminary evaluation of 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG):: A new potential imaging agent for viral infection and gene therapy using PET [J].
Alauddin, MM ;
Conti, PS .
NUCLEAR MEDICINE AND BIOLOGY, 1998, 25 (03) :175-180
[5]  
Alauddin MM, 2004, J NUCL MED, V45, P2063
[6]   Synthesis of 2′-deoxy-2′-[18F]fluoro-5-bromo-1-β-D-arabinofuranosyluracil ([18F]-FBAU) and 2′-deoxy-2′-[18F]fluoro-5-chloro-1-β-D-arabinofuranosyl-uracil ([18F]-FCAU), and their biological evaluation as markers for gene expression [J].
Alauddin, MM ;
Shahinian, A ;
Park, R ;
Tohme, M ;
Fissekis, JD ;
Conti, PS .
NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (04) :399-405
[7]   Evaluation of 9-[(3-18F-fluoro-1-hydroxy-2-propoxy)methyl]guanine ([18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors [J].
Alauddin, MM ;
Shahinian, A ;
Kundu, RK ;
Gordon, EM ;
Conti, PS .
NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (04) :371-376
[8]  
Alauddin MM, 2001, J NUCL MED, V42, P1682
[9]   Pharmacokinetics of the thymidine analog 2′-fluoro-5-[14C]-methyl-1-β-D-arabinofuranosyluracil ([14C]FMAU) in rat prostate tumor cells [J].
Bading, JR ;
Shahinian, AH ;
Bathija, P ;
Conti, PS .
NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (04) :361-368
[10]   Pharmacokinetics of the thymidine analog 2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats [J].
Bading, JR ;
Shahinian, AH ;
Vail, A ;
Bathija, P ;
Koszalka, GW ;
Koda, RT ;
Alauddin, MM ;
Fissekis, JD ;
Conti, PS .
NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (04) :407-418